COVID-19 Guidance for Research/Clinical Trials


The HNE Research Office has received COVID-19 guidance for research / clinical trials  from 3 levels as follows: 


- Local

Guidance for human research activities during COVID-19

This guidance advice is for those involved in human research initiatives.  It is based on the collective expertise of the Human Research Ethics Committees at the University of Newcastle and the Hunter New England Local Health District.


- State


 This guidance has been provided to minimise the adverse health impacts on clinical trial participants as well as site, sponsor and vendor staff involved in clinical trials. Emphasis is placed on managing burden and disruption to health-related services in NSW at this critical time. 


- National


This guidance provides general information and advice to institutions conducting or overseeing research, Human Research Ethics Committees (HRECs), researchers and sponsors in the context of the COVID-19 pandemic. It is directed towards those involved in clinical trial research and other relevant clinical research, but also may be of use to institutions, HRECs and researchers in other fields.


If you have any questions, please contact the HNE Research Office;